Why pharma is not an ordinary consumer market
Someone in Tashkent with a cold may walk into the nearest pharmacy and ask the pharmacist what to take. A patient with a chronic condition usually buys what the doctor prescribed and rarely changes the plan alone. These are two different buying journeys, and they need different research.
The market also splits into segments: prescription drugs, over-the-counter products, vitamins and supplements, medical devices, and purchases by hospitals and clinics. Each has its own questions, methods and permitted ways of communicating. So the first decision is which segment you are actually studying.
Map who influences the choice
Before writing a questionnaire, draw the decision chain. Many companies study only the buyer and miss the people who actually steer the choice.
- Doctor: prescribes and decides which drugs count as interchangeable
- Pharmacist: advises and suggests alternatives, especially for OTC products
- Patient and family: weigh price, availability and how easy the regimen is to follow
- Pharmacy or chain: decides what to stock and how to display it
- Distributor: determines what really reaches a given region, and when
- Hospital buyer: works under its own rules and procedures
How to study pharmacies
The pharmacy shows the market as it really is: what is in stock, which alternatives sit next to your product, where shelves keep running empty. Regular audits of a few dozen outlets across Tashkent and regional centers tell you more than a distributor's polished presentation.
Interviews with pharmacy managers and pharmacists explain why a product is stocked or dropped: supply terms, trust in the manufacturer, turnover, demand. A mystery shopper shows what a pharmacist recommends for a typical no-prescription request and when a substitute is offered.
- Audit of availability, prices, shelf position and neighboring alternatives
- Interviews with managers and pharmacists
- Mystery shopping for common requests
- Distributor data split by region
Doctors and patients: two different conversations
For prescription drugs, the doctor is the key figure. You ask how they choose a drug for a specific diagnosis, which sources they trust and what they know about new products. The conversation should be short, prepared and voluntary. If the questions read like hidden advertising, the answers get distorted and the ethics suffer.
Patients are studied to understand the treatment path: when symptoms are noticed, when a doctor is visited, where medicine is bought and why a course gets abandoned. This matters most for long-term and OTC products. When collecting such data, follow the rules on personal data and medical confidentiality.
Desk research before you go into the field
Part of the picture can be assembled from a desk. It is cheaper and works well for a first assessment of a niche.
- The register of authorized medicines, to list competitors and alternatives
- Online pharmacies and drug-search services: range, prices, availability, reviews
- Announcements from the sector regulator about changes in the rules
- Industry association reports, where they are available
- Discussions in Telegram and Instagram, as a signal rather than a sample
Regulation and ethics
Before the research, and certainly before using the findings in promotion, study the current requirements on advertising medicines and on working with medical professionals. The rules differ for prescription and OTC products, supplements and devices. Participation in surveys must be voluntary, and any compensation must be transparent and lawful. If something is unclear, have a lawyer review your wording.
What a good study delivers, and common mistakes
A good study ends in decisions: which segment and region have room, who influences the choice most, what blocks the patient, and how to adjust range, distribution and sales-rep training.
The mistakes repeat. Teams interview only patients and forget doctors and pharmacists. They draw conclusions from a single pharmacy chain. They copy findings from other countries without checking local practice. Or they plan promotion without checking advertising rules first.
If you want to tie this kind of research to a wider marketing strategy, the markdev team can help define the questions, choose the methods and turn the data into an action plan. Tell us about your task and we will discuss where it makes sense to start.
FAQ
Where should pharmaceutical market research start?
With the segment you care about (prescription, OTC, supplements, devices) and a map of who influences the choice. Then collect desk data, and only after that plan pharmacy audits, interviews and surveys.
Is it acceptable to survey doctors?
Yes, provided participation is voluntary, the questions are neutral, and the format and any compensation comply with current rules. Check doubtful points with a lawyer in advance.
Is data from one pharmacy chain enough?
No. One chain reflects its own policy and its own customers. You need different pharmacy formats and several regions before drawing conclusions.
How does this help a small manufacturer or distributor?
It shows where there is free space on the shelf, which alternatives compete with you, and which pharmacies and regions to prioritize, so the budget is not spent blindly.
Let’s look at your task for free
Leave your contact — in a 15-minute call we’ll show where leads get lost and what to fix first.